Zatloukal P, Dudková V, Mĕricka O
I. klinika tuberkulózy a respiracních nemocí 1. lékarské fakulty Univerzity Karlovy, Praha.
Sb Lek. 1990 Nov-Dec;92(11-12):366-9.
In 77 patients with bronchogenic carcinoma and 46 patients with non-tumorous lung diseases the serum concentration of beta-2-microglobulin was assessed. The revealed differences between groups were not statistically significant. The group with bronchogenic carcinoma was sub-divided by morphological types: epidermoid carcinoma, adenocarcinoma, small-cell and large cell carcinoma. The group of large cell carcinomas was too small for statistical evaluation, the other differences between different morphological types were not statistically significant. Assessment of the serum concentration of beta-2-microglobulin is of no value in the differential diagnosis of bronchogenic carcinoma.
对77例支气管源性癌患者和46例非肿瘤性肺部疾病患者的血清β2-微球蛋白浓度进行了评估。两组之间的差异无统计学意义。支气管源性癌组按形态学类型分为：鳞状细胞癌、腺癌、小细胞癌和大细胞癌。大细胞癌组因样本量太小无法进行统计学评估，不同形态学类型之间的其他差异无统计学意义。血清β2-微球蛋白浓度评估在支气管源性癌的鉴别诊断中无价值。
